Literature DB >> 6822165

Prophylactic oophorectomy in surgery for large-bowel cancer.

R Cutait, M L Lesser, W E Enker.   

Abstract

From 1968 to 1975, 201 women had prophylactic oophorectomy at the time of definitive large-bowel resection, while in 134 patients oophorectomy was not performed. Oophorectomy was performed more commonly in women with cancer of the rectum and rectosigmoid. More patients undergoing oophorectomy had Dukes' C primary carcinoma. Four patients undergoing synchronous oophorectomy (2.0 per cent) had ovarian involvement or metastases from large-bowel cancer. Three patients (2.2 per cent) developed subsequent ovarian disease: two cases of ovarian carcinoma and one case of ovarian metastases from primary breast cancer. No late ovarian recurrences of large-bowel cancer were seen during this study. No patient with ovarian involvement or metastases from large-bowel cancer survived five years nor was the overall survival of the group of women undergoing oophorectomy materially affected. While stage and site significantly influenced survival, oophorectomy, menopausal status, preoperative irradiation, tumor size, and degree of differentiation had no influence. The prevention of primary ovarian cancer in postmenopausal women is considered to be the main benefit of bilateral prophylactic oophorectomy. Selective recommendations for oophorectomy under other circumstances are discussed.

Entities:  

Mesh:

Year:  1983        PMID: 6822165     DOI: 10.1007/bf02554669

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  10 in total

1.  Oophorectomy in primary colorectal cancer.

Authors:  A Schofield; J Pitt; G Biring; P M Dawson
Journal:  Ann R Coll Surg Engl       Date:  2001-03       Impact factor: 1.891

2.  Clinicopathologic Characteristics and Impact of Oophorectomy for Ovarian Metastases from Colorectal Cancer.

Authors:  Carling Ursem; Margaret Zhou; Alan Paciorek; Chloe E Atreya; Andrew H Ko; Alan Venook; Li Zhang; Katherine Van Loon
Journal:  Oncologist       Date:  2020-02-07

3.  Ovarian metastases in young women with colorectal cancer: a retrospective multicenter cohort study.

Authors:  R van der Meer; C Bakkers; J A Wegdam; T Lettinga; E G Boerma; F Aarts; I H J T de Hingh; R M H Roumen
Journal:  Int J Colorectal Dis       Date:  2022-07-20       Impact factor: 2.796

4.  Oophorectomy and colon cancer. Impact on survival.

Authors:  G H Ballantyne; M M Reigel; B G Wolff; D M Ilstrup
Journal:  Ann Surg       Date:  1985-08       Impact factor: 12.969

5.  "Ovarian Metastases from Colorectal Cancer: Our Experience".

Authors:  Vasu Reddy Challa; Y G Basavana Goud; Poornima Rangappa; Vijayalakshmi Deshmane; K V Veerendra Kumar; B A Madhusudhana
Journal:  Indian J Surg Oncol       Date:  2014-12-27

6.  Ovarian metastases of colorectal and duodenal cancer in familial adenomatous polyposis.

Authors:  Stijn Crobach; Tom van Wezel; Hans F Vasen; Hans Morreau
Journal:  Fam Cancer       Date:  2012-12       Impact factor: 2.375

7.  En bloc pelvic lymphadenectomy and sphincter preservation in the surgical management of rectal cancer.

Authors:  W E Enker; S J Pilipshen; M L Heilweil; M W Stearns; A J Janov; R E Hertz; S S Sternberg
Journal:  Ann Surg       Date:  1986-04       Impact factor: 12.969

8.  The role of chemotherapy and prophylactic bilateral oophorectomy in a case of colorectal adenocarcinoma with ovarian metastases.

Authors:  E K Shin; B T Takizawa; L Masters; S Shahabi
Journal:  Yale J Biol Med       Date:  2001 Mar-Apr

9.  Bilateral ovarian micrometastatic adenocarcinoma upon prophylactic oophorectomy concurrent with low anterior resection for rectal cancer.

Authors:  Robin Irons; Erin McIntosh; Alexandre Hageboutros; David Warshal; Steven McClane
Journal:  World J Surg Oncol       Date:  2017-02-07       Impact factor: 2.754

10.  Is cell block technique useful to predict histological type in patients with ovarian mass and/or body cavity fluids?

Authors:  Zenta Maseki; Hiroaki Kajiyama; Eri Nishikawa; Tatsunari Satake; Toshiya Misawa; Fumitaka Kikkawa
Journal:  Nagoya J Med Sci       Date:  2020-05       Impact factor: 1.131

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.